Ethical microbiome research with Indigenous communities: A framework for collaboration and sovereignty

Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and diabetes.

Blood Markers Help Predict MS Disease Progression

Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse activity (PIRA) in multiple sclerosis (MS), an observational study suggested.

September 20, 2024

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, “IPIAD- an augmentation regimen added to standard treatment of pancreatic

February 10, 2024

Novel Drug Improves Depression, Insomnia Symptoms as Add-On Therapy

Investigational seltorexant improved symptoms of major depressive disorder (MDD) and insomnia in people with an inadequate response to antidepressants, a phase III trial indicated. By

November 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.